Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Novonesis A/S is a biotechnology company formed in January 2024 through the merger of Novozymes and Chr. Hansen. Headquartered in Lyngby, Denmark, the company specializes in developing biosolutions, including enzymes, functional proteins, and microorganisms, serving over 30 industries such as food and beverage, agriculture, and pharmaceuticals. With a global presence encompassing more than 23 manufacturing sites and nearly 40 R&D and application centers, Novonesis employs approximately 10,000 individuals worldwide. The company is committed to sustainability, aiming for carbon neutrality by 2050 and a 75% reduction in scope 1 and 2 emissions by 2030. Novonesis leverages its extensive expertise to create innovative biosolutions that address global challenges in health, nutrition, and environmental sustainability.
View stock
VS
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.
View stock

Stock highlights

Stock comparison highlights
Stock name
Novonesis A/SLinde
Last price
€61.68$514.24
Currency
EUR
USD
€29B$236B
45.5634.17
€1.35$15.05
0.620.71
€0.88$6.30
1.43%1.24%
Sector
MaterialsMaterials
Employees
11,09864,649
Ticker
€NSISB$LIN
Primary listing
XGATNASDAQ

Performance

CumulativeRolling yearsLump sum investment

Invest in €NSISB or $LIN on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.